Clinical & Translational Oncology
- ISSN:
- 1699-048X
1
h-index
5
Citations
9
Works
1.00
2-year mean citedness
Trust signals
1 of 3 signals presentIndependent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.
- DOAJNo datadoaj.org
- OAK listNo dataOAK
- Valid ISSNPresentISSN
This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.
Trends over time
Performance over time
Citation overview
Publications (bars) and citations (line) by year
- Publications
- Citations
Citation history
Publication history
h-index evolution
Cumulative h-index by year
Most-cited works
- Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis20252 citations
- Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology20261 citations
- The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials20261 citations
- Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis20251 citations
- CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy20260 citations
- Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer20260 citations
- Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy20260 citations
- CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy20260 citations
- Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities20260 citations